CME/CE
Your professional development is critical to the care of your patients. Stay on top of the latest treatments and information with ReachMD's CME activities. Our topics span cardiology, diabetes, oncology, women's health and more. And our CME library is continuously growing, every quarter.
706-720 of 973
Understanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
CME/CEUnderstanding the Unmet Needs of Women Impacted by PTSD: A Comprehensive Overview
Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
MinuteCE®Optimizing HF Outcomes Across the Spectrum: Emerging Evidence
Empowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
CME/CEEmpowering Choices: Navigating Early-Stage HR+, HER2- Breast Cancer with CDK4/6 Inhibition
Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
MinuteCE®Challenges of managing hyperkalemia in HF patients with CKD while maintaining RAAS inhibitor therapy
- advertisement
A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
MinuteCE®A multidisciplinary clinical dialogue: Optimizing long-term goals: practical approaches to novel potassium binder use in cardiorenal care
Summarizing multidisciplinary strategies: Where do we go from here?
MinuteCE®Summarizing multidisciplinary strategies: Where do we go from here?
New Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
CME/CENew Horizons: Unraveling Novel Therapies for Enhanced Cardiovascular Outcomes in Patients With Heart Failure
Partnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
CME/CEPartnering for Progress: A Case Study in Patient-Centered Hyperkalemia Management
What do we know now that could have changed the history of CETP inhibition?: genetics and biology
MinuteCE®What do we know now that could have changed the history of CETP inhibition?: genetics and biology
- advertisement
CETP inhibition: Lessons from two decades of clinical trials
MinuteCE®CETP inhibition: Lessons from two decades of clinical trials
A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
MinuteCE®A novel CETP inhibitor to target CV risk reduction: Where could it fit in future lipid management?
